ArticleTherapeutic advances in medical oncology2021

IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer.

Stephen P Hack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.